GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,798,000 | -13.6% | 41,300 | -13.6% | 0.17% | +1.2% |
| Q1 2022 | $2,082,000 | -1.2% | 47,800 | 0.0% | 0.16% | +0.6% |
| Q4 2021 | $2,108,000 | +85.7% | 47,800 | +60.9% | 0.16% | +71.6% |
| Q3 2021 | $1,135,000 | -8.0% | 29,700 | -4.1% | 0.10% | -3.1% |
| Q2 2021 | $1,234,000 | +4.8% | 30,983 | -6.1% | 0.10% | -3.0% |
| Q1 2021 | $1,177,000 | -8.5% | 32,983 | -5.7% | 0.10% | -18.5% |
| Q4 2020 | $1,287,000 | -2.5% | 34,983 | -0.2% | 0.12% | -13.9% |
| Q3 2020 | $1,320,000 | -10.3% | 35,060 | -2.8% | 0.14% | -18.6% |
| Q2 2020 | $1,471,000 | +5.5% | 36,060 | -2.0% | 0.18% | -2.7% |
| Q1 2020 | $1,394,000 | -20.0% | 36,783 | -0.8% | 0.18% | +5.2% |
| Q4 2019 | $1,743,000 | +10.1% | 37,083 | 0.0% | 0.17% | -6.5% |
| Q3 2019 | $1,583,000 | +6.4% | 37,083 | -0.3% | 0.18% | +5.1% |
| Q2 2019 | $1,488,000 | -5.9% | 37,183 | -1.8% | 0.18% | -5.4% |
| Q1 2019 | $1,582,000 | +9.3% | 37,866 | 0.0% | 0.19% | -4.1% |
| Q4 2018 | $1,447,000 | -4.9% | 37,866 | 0.0% | 0.19% | +8.4% |
| Q3 2018 | $1,521,000 | -0.3% | 37,866 | 0.0% | 0.18% | -6.8% |
| Q2 2018 | $1,526,000 | -6.0% | 37,866 | -8.9% | 0.19% | -7.7% |
| Q1 2018 | $1,623,000 | +84.9% | 41,549 | +67.9% | 0.21% | +118.9% |
| Q4 2017 | $878,000 | -18.5% | 24,749 | -6.7% | 0.10% | -22.1% |
| Q3 2017 | $1,077,000 | -12.7% | 26,522 | -7.2% | 0.12% | -12.9% |
| Q2 2017 | $1,233,000 | +2.3% | 28,586 | 0.0% | 0.14% | 0.0% |
| Q1 2017 | $1,205,000 | -29.2% | 28,586 | -35.3% | 0.14% | -31.7% |
| Q4 2016 | $1,701,000 | +17.6% | 44,176 | +31.7% | 0.20% | +15.8% |
| Q3 2016 | $1,447,000 | -5.9% | 33,544 | -5.4% | 0.18% | -9.7% |
| Q2 2016 | $1,537,000 | +7.2% | 35,463 | +0.3% | 0.20% | +6.5% |
| Q1 2016 | $1,434,000 | +3.5% | 35,363 | +3.0% | 0.18% | +4.5% |
| Q4 2015 | $1,385,000 | +12.8% | 34,334 | +7.5% | 0.18% | +8.6% |
| Q3 2015 | $1,228,000 | -3.5% | 31,934 | +4.6% | 0.16% | +9.5% |
| Q2 2015 | $1,272,000 | -5.7% | 30,534 | +4.4% | 0.15% | -6.3% |
| Q1 2015 | $1,349,000 | -4.0% | 29,241 | -11.0% | 0.16% | -6.0% |
| Q4 2014 | $1,405,000 | -1.0% | 32,866 | +6.4% | 0.17% | -2.9% |
| Q3 2014 | $1,419,000 | -15.1% | 30,877 | -1.2% | 0.17% | -19.2% |
| Q2 2014 | $1,672,000 | +0.4% | 31,267 | +0.3% | 0.21% | -4.9% |
| Q1 2014 | $1,665,000 | +0.4% | 31,162 | +0.4% | 0.22% | -0.4% |
| Q4 2013 | $1,658,000 | +7.1% | 31,052 | +0.6% | 0.23% | -0.9% |
| Q3 2013 | $1,548,000 | +1.6% | 30,852 | +1.1% | 0.23% | -8.1% |
| Q2 2013 | $1,524,000 | – | 30,502 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |